companies / dalanbio-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-02 json
| total_raised | 3,000,0003.0M | ○ |
|---|---|---|
| founded | 2018 | |
| hq | Athens, GA | |
| industry | unknown | |
| stage | seed |
Dalan Animal Health develops vaccines for underserved production animals such as honeybees and shrimp, including the first vaccine protecting honeybees against American Foulbrood. It serves beekeepers, aquaculture producers, and the broader animal-health industry. Its oral, queen-administered approach primes larvae against disease without antibiotics, with a USDA-conditional license for its bee vaccine.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2026-04-01 | grant | 2,700,0002.7M | null | ○ |
| fact | status | src |
|---|---|---|
| Grant, $2.7M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |